| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 03/06/2003 | WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 03/06/2003 | WO2002066516A3 Antibodies that bind both bcma and taci |
| 03/06/2003 | WO2002060929A3 Polymer conjugates of neublastin and methods of using same |
| 03/06/2003 | WO2002005797A8 Use of dopamine d2/d3 receptor agonists to treat fibromyalgia |
| 03/06/2003 | WO2001092304A3 Transporters and ion channels |
| 03/06/2003 | US20030045556 Aryl-N-cyanoguanidines and methods related thereto |
| 03/06/2003 | US20030045529 Method for specifically potentiating N-type Ca2+ channel activity |
| 03/06/2003 | CA2458574A1 Reagents and methods for smooth muscle therapies |
| 03/06/2003 | CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 03/06/2003 | CA2458261A1 Differentiation of neural stem cells and therapeutic use thereof |
| 03/06/2003 | CA2458131A1 Jnk activation inhibitor |
| 03/06/2003 | CA2457885A1 Antimicrobial and anti-inflammatory peptides |
| 03/06/2003 | CA2457846A1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 03/06/2003 | CA2455497A1 Amidine derivatives for treating amyloidosis |
| 03/06/2003 | CA2455311A1 Rapamycin dialdehydes |
| 03/05/2003 | EP1288299A2 TRNA synthetase |
| 03/05/2003 | EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 03/05/2003 | EP1287134A2 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 03/05/2003 | EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/05/2003 | EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/05/2003 | EP1286989A2 Prodrug of an ice inhibitor |
| 03/05/2003 | EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/05/2003 | EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 03/05/2003 | EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions |
| 03/05/2003 | EP1286683A2 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs |
| 03/05/2003 | EP1286659A2 Macromolecular drug complexes and compositions containing the same |
| 03/05/2003 | EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/05/2003 | EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/05/2003 | EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS |
| 03/05/2003 | EP0874851B1 Macrocyclic compounds made from carbon suboxide units |
| 03/05/2003 | CN1400904A Selective estrogen receptor modulators in combination with estrogens |
| 03/04/2003 | US6528542 Adjustment concentration |
| 03/04/2003 | US6528533 Treating or preventing neuronal damage associated with neurological diseases; hydrazide based compounds containing the group -N-N-CO-X- where X is C,O,S,or N |
| 03/04/2003 | US6528524 Treating the multiple drug resistance, arrhythmia, spasms and malaria; reacting hydrochloric acid with cinchonine or to cinchonine monohydrochloride in form cinchonine dihydrochloride; high purity |
| 03/04/2003 | US6528512 Cytokine specific binding protein; |
| 03/04/2003 | US6528509 Pyrazole compositions useful as inhibitors of ERK |
| 03/04/2003 | US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli |
| 03/04/2003 | US6528312 Nuclease inhibitor (G-Actin) or interleukin-10 (IL-10) use improving cell transfection; mixtures; polynucleotides; use gene therapy, vaccines |
| 02/27/2003 | WO2003016549A2 Nucleic-acid associated proteins |
| 02/27/2003 | WO2003016530A1 Novel protein and its dna |
| 02/27/2003 | WO2003016493A2 Transporters and ion channels |
| 02/27/2003 | WO2003016351A2 N - cam related compounds modulating cell groth |
| 02/27/2003 | WO2003016335A2 Irreversible cysteine protease inhibitors of legumain |
| 02/27/2003 | WO2003016311A1 Tricyclic pyridin-2-one analogues as ligands for gaba-a receptors |
| 02/27/2003 | WO2003016291A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ |
| 02/27/2003 | WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 02/27/2003 | WO2003015794A1 Methods and compositions for treating apoptosis associated disorders |
| 02/27/2003 | WO2003015772A1 Inhibitors of polyq-aggregation |
| 02/27/2003 | WO2003015710A2 Combined drug and csf removal therapies and systems |
| 02/27/2003 | WO2003015615A2 Treatment of muscular dystrophies and related disorders |
| 02/27/2003 | WO2003015516A1 Compositions and methods for treatment of mitochondrial diseases |
| 02/27/2003 | WO2003015494A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 02/27/2003 | WO2003001881A3 Cell-based high-throughput screening methods |
| 02/27/2003 | WO2002080851A3 Chimeric vaccines |
| 02/27/2003 | WO2002028425A3 Methods for treating muscle injuries |
| 02/27/2003 | WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 02/27/2003 | US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 02/27/2003 | US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof |
| 02/27/2003 | US20030040541 Administering bismuth subgallate to inhibit the production of nitric oxide synthases (NOS) |
| 02/27/2003 | US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 02/27/2003 | US20030040533 For use as hypoglycaemic and hypolipidaemic agents |
| 02/27/2003 | US20030040512 Pharmaceutical composition with protective action against oxidative/toxic substances, especially cardiotoxic substances |
| 02/27/2003 | US20030040510 Selective estrogen receptor modulators in combination with estrogens |
| 02/27/2003 | US20030040044 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039629 Espression enhancer for protein synthesis inhibitory genes |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2458068A1 Methods and compositions for treating apoptosis associated disorders |
| 02/27/2003 | CA2457453A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 02/27/2003 | CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | CA2457164A1 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 02/27/2003 | CA2456868A1 Inhibitors of polyq-aggregation |
| 02/27/2003 | CA2456743A1 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 02/27/2003 | CA2455884A1 Treatment of muscular dystrophies and related disorders |
| 02/26/2003 | EP1285664A2 Methods of increasing lean tissue mass using OB protein compositions |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285000A2 Use of adnf for enhancing learning and memory |
| 02/26/2003 | EP1284999A2 Repair of nerve damage |
| 02/26/2003 | EP1284958A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 02/26/2003 | EP1284753A2 Combination of growth hormone secretagogues and antidepressants |
| 02/26/2003 | EP1100797B1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/26/2003 | EP0929571B1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399633A 嘧啶衍生物 Pyrimidine derivatives |
| 02/26/2003 | CN1399630A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 02/26/2003 | CN1399559A Micro-cluster liquids and methods of making and using them |
| 02/25/2003 | US6525206 Compounds with high monoamine transporter affinity |
| 02/25/2003 | US6525196 5HT1 antagonists for antidepressant therapy |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/25/2003 | US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders |
| 02/25/2003 | US6524629 20-30% of flavoneglycosides, 2.5-4.5% of ginkgolides A, B, C, and J, 2-4% of biloblaide, < 10% proanthocyanidines, < 10 ppm of an alkylphenol and ginkobiloba extract |
| 02/21/2003 | WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/21/2003 | CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/20/2003 | WO2003014326A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |